FXR suppresses colorectal cancer by inhibiting the Wnt/β-catenin pathway via activation of TLE3
返回论文页
Short communication|更新时间:2023-08-29
|
FXR suppresses colorectal cancer by inhibiting the Wnt/β-catenin pathway via activation of TLE3
Genes & DiseasesVol. 10, Issue 3, (2023)
作者机构:
Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin Carbone Cancer Center (UWCCC), University of Wisconsin–, Madison,WI,Madison,USA,53705
Xingchen Dong, Chunmiao Cai, Ting Fu. FXR suppresses colorectal cancer by inhibiting the Wnt/β-catenin pathway via activation of TLE3. [J]. Genes & Diseases 10(3).(2023)
DOI:
Xingchen Dong, Chunmiao Cai, Ting Fu. FXR suppresses colorectal cancer by inhibiting the Wnt/β-catenin pathway via activation of TLE3. [J]. Genes & Diseases 10(3).(2023) DOI: 10.1016/j.gendis.2022.09.006.
FXR suppresses colorectal cancer by inhibiting the Wnt/β-catenin pathway via activation of TLE3